SISB INVESTMENT ADVISERS (UK) LTD

Institutional investor · Portfolio as of Q4 2019

Top Holdings5 positions

Checking export access…
Activity:

UBER TECHNOLOGIES INC

222.2M$6.6B72.4%$46.38-35.88%
3 qtrssince 2019-Q2
Unchanged
0

GUARDANT HEALTH INC

23M$1.8B19.7%$40.56+92.10%
5 qtrssince 2018-Q4
Unchanged
0
WORKWORKDelisted

Slack Technologies Inc.

17.5M$392.5M4.3%——
2 qtrssince 2019-Q3
Unchanged
0

VIR BIOTECHNOLOGY INC

22.6M$284.4M3.1%$12.120.00%
1 qtr
New
88
OCFTOCFTDelisted
ADR

ONECONNECT FINANCIAL TECHNO

4.4M$44.6M0.5%——
1 qtr
New
51
$9.1B
AUM
5
Positions
Q4 2019
Filing
HI score · 1.5/5
Quarterly 13F Value Change
Not enough history yet
Activity profile
$ moved · Q4'19
New100%Increased0%Decreased0%Exited0%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 1.4 quarters
<1Q40%1-4Q40%1-2Y20%2Y+0%

SB INVESTMENT ADVISERS (UK) LTD manages $9.1B across 5 positions as of Q4 2019. Top holdings: UBER (72.4%), GH (19.7%), WORK (4.3%). Fund DNA: Concentrated Value. HoldingsIntel Score: 1.5/5.0.

Q4 2019 Summary

Added 2 new positions. Top move: VIR (NEW, conviction 88). Portfolio: $9.1B across 5 positions.

Top holdings by portfolio weight

Total AUM$9B
UBER72.44%
GH19.66%
WORK4.30%
VIR3.12%
OCFT0.49%

Portfolio allocation by GICS sector

Sectors3
Technology72.44%
Healthcare22.77%
Unknown4.79%

Behavioral investing profile

Checking access…
Concentrated Value- primarily Technology, Healthcare
Compare DNA across all funds
7-dimension, SEC 13F-derived research score
Below Average(1.5 / 5.0)
Holdings P&L14
Conviction37
Concentration100
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

No active accumulation streaks detected for this filer.

Streaks require 2+ consecutive quarters of increased positions in the most recent period.

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Verify source filings on SEC EDGAR

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used